AI
AstraZeneca and insitro Launch AI Drug Discovery Collaboration
AstraZeneca and insitro have formed an AI-focused partnership to develop treatments for heart and liver diseases in a deal potentially worth up to $1.5 billion.
October 15, 2026, 03:04 PM·ForkLog
